» Articles » PMID: 35356253

Prp19 Facilitated P21-Dependent Senescence of Hepatocellular Carcinoma Cells

Overview
Journal J Oncol
Specialty Oncology
Date 2022 Mar 31
PMID 35356253
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Evidence suggests that the role of senescence in the development of cancer is context-dependent. An orthologue of human pre-mRNA processing factor 19 (Prp19) attenuates the senescence of human endothelial cells. Prp19 has been reported to be involved in the progression of hepatocellular carcinoma (HCC). This work aims to investigate the effect of Prp19 on the senescence of HCC.

Materials And Methods: Senescence of L02 cells and HCC cells under different stimuli was detected through cell cycle analysis, SA--gal staining, and senescence associated secretory phenotype analysis. The relationship between Prp19 and senescence-related proteins was evaluated using real-time RT-PCR, western blot assay, and immunohistochemistry. Subcutaneous xenograft tumors in nude mice were used to evaluate the role of Prp19 on senescence . Data analysis was carried out using GraphPad Prism 6.

Results: Prp19 facilitated the senescence of L02 cells and HCC cells under different stresses. Prp19 positively modulated p21 expression in the mRNA level. Downregulation of Prp19 promoted the growth of subcutaneous xenograft tumors generated by HCC cell lines.

Conclusions: Prp19 may promote senescence of HCC cells via regulating p21 expression.

Citing Articles

Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis.

Liu Z, Lin X, Zhang D, Guo D, Tang W, Yu X Adv Sci (Weinh). 2024; 11(46):e2407517.

PMID: 39422063 PMC: 11633487. DOI: 10.1002/advs.202407517.


PRPF19 modulates morphology and growth behavior in a cell culture model of human skin.

Kleissl L, Weinmullner R, Lammermann I, Dingelmaier-Hovorka R, Jafarmadar M, El Ghalbzouri A Front Aging. 2023; 4:1154005.

PMID: 37214773 PMC: 10196211. DOI: 10.3389/fragi.2023.1154005.

References
1.
Iwagami Y, Huang C, Olsen M, Thomas J, Jang G, Kim M . Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma. Hepatology. 2015; 63(4):1213-26. PMC: 4805474. DOI: 10.1002/hep.28411. View

2.
Borghesan M, Fusilli C, Rappa F, Panebianco C, Rizzo G, Oben J . DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression. Cancer Res. 2016; 76(3):594-606. PMC: 4785885. DOI: 10.1158/0008-5472.CAN-15-1336. View

3.
Kang T, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D . Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 2011; 479(7374):547-51. DOI: 10.1038/nature10599. View

4.
Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M . Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol. 2012; 58(4):724-9. DOI: 10.1016/j.jhep.2012.11.009. View

5.
Nault J, Ningarhari M, Rebouissou S, Zucman-Rossi J . The role of telomeres and telomerase in cirrhosis and liver cancer. Nat Rev Gastroenterol Hepatol. 2019; 16(9):544-558. DOI: 10.1038/s41575-019-0165-3. View